LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Alphabet Inc.'s Holding History (CIK: 0001652044)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 5,865,125 Value ($000) $3,167 Avg Close — Range —
Q4 2024
Shares 5,865,125 Value ($000) $3,754 Avg Close — Range —
Q3 2024
Shares 5,865,125 Value ($000) $8,094 Avg Close — Range —
Q2 2024
Shares 5,865,125 Value ($000) $8,504 Avg Close — Range —
Q1 2024
Shares 5,865,125 Value ($000) $13,079 Avg Close — Range —
Q4 2023
Shares 5,865,125 Value ($000) $11,378 Avg Close — Range —
Q3 2023
Shares 5,865,125 Value ($000) $8,622 Avg Close — Range —
Q2 2023
Shares 5,865,125 Value ($000) $18,651 Avg Close — Range —
Q1 2023
Shares 5,865,125 Value ($000) $13,842 Avg Close — Range —
Q4 2022
Shares 5,865,125 Value ($000) $20,352 Avg Close — Range —
Q3 2022
Shares 5,865,125 Value ($000) $42,991 Avg Close — Range —
Q2 2022
Shares 5,865,125 Value ($000) $38,241 Avg Close — Range —
Q1 2022
Shares 5,865,125 Value ($000) $29,619 Avg Close — Range —
Q4 2021
Shares 5,865,125 Value ($000) $45,396 Avg Close — Range —
Q3 2021
Shares 5,865,125 Value ($000) $86,804 Avg Close — Range —
Q2 2021
Shares 5,865,125 Value ($000) $95,250 Avg Close — Range —